99-27332. National Institute on Drug Abuse; Notice of Closed Meeting  

  • [Federal Register Volume 64, Number 202 (Wednesday, October 20, 1999)]
    [Notices]
    [Page 56512]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-27332]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Institute on Drug Abuse; Notice of Closed Meeting
    
        Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
    meeting.
        The meeting will be closed to the public in accordance with the 
    provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
    U.S.C., as amended. The grant applications and the discussions could 
    disclose confidential trade secrets or commercial property such as 
    patentable material, and personal information concerning individuals 
    associated with the grant applications, the disclosure of which would 
    constitute a clearly unwarranted invasion of personal privacy.
    
        Name of Committee: National Institute on Drug Abuse Special 
    Emphasis Panel, Minority Institutions Drug Abuse Research 
    Development Program.
        Date: November 1, 1999.
        Time: 10 am to 1 pm.
        Agenda: To review and evaluate grant applications.
        Place: Neuroscience Center, National Institutes of Health, 6001 
    Executive Blvd., Bethesda, MD 20892.
        Contact Person: Marina L. Volkov, Special Expert, Office of 
    Extramural Program Review, National Institute on Drug Abuse, 
    National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
    3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.
    
    (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
    Abuse Scientist Development Award for Clinicians, Scientist 
    Development Awards, and Research Scientist Awards; 93.278, Drug 
    Abuse National Research Service Awards for Research Training; 
    93.279, Drug Abuse Research Programs, National Institutes of Health, 
    HHS)
    
        Dated: October 13, 1999.
    LaVerne Y. Stringfield,
    Director, Office of Federal Advisory Committee Policy.
    [FR Doc. 99-27332 Filed 10-19-99; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
11/1/1999
Published:
10/20/1999
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
99-27332
Dates:
November 1, 1999.
Pages:
56512-56512 (1 pages)
PDF File:
99-27332.pdf